Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Thomas S. Bowman"'
Autor:
John M. Lasala, Emmanouil S. Brilakis, Ruth M. Starzyk, Thomas S. Bowman, David A. Cox, Keith D. Dawkins
Publikováno v:
Journal of Interventional Cardiology. 24:342-350
Aims: Examine the incidence of clinical events after utilization of the TAXUS® Express® paclitaxel-eluting stent (PES) in multivessel and bifurcation coronary stenting in an unselected patient population. Methods and Results: The ARRIVE Program com
Autor:
Pei-Hsiu Huang, Ruth M. Starzyk, M.P.H. Thomas S. Bowman M.D., David A. Cox, Keith D. Dawkins, Michael Yeung, John M. Lasala
Publikováno v:
Journal of Interventional Cardiology. 24:232-240
Aims: To examine the incidence of clinical events after implantation of the TAXUS Express paclitaxel-eluting stent (PES) in chronic total occlusions (CTO) in an unselected patient population. Methods and Results: The TAXUS ARRIVE registries compiled
Autor:
Thomas S. Bowman, Emmanouil S. Brilakis, Keith D. Dawkins, Ruth M. Starzyk, David A. Cox, John M. Lasala, Peter B. Berger
Publikováno v:
JACC: Cardiovascular Interventions. 3:742-750
Objectives The aim of this study was to examine the incidence of clinical events after implantation of the TAXUS Express (Boston Scientific Corporation, Natick, Massachusetts) paclitaxel-eluting stent in saphenous vein graft (SVG) lesions in an unsel
Autor:
Thomas S. Bowman, Howard D. Sesso, J. Michael Gaziano, I. Min Lee, JoAnn E. Manson, Lydia C. Siegel
Publikováno v:
The American Journal of Medicine. 122:1115-1121
Objective Physical activity has been associated with lower diabetes risk, but several prospective studies among women found that activity only slightly attenuated the diabetes risk associated with high body mass index (BMI). We investigated the indep
Autor:
Charles O'Shaughnessy, Stephen G. Ellis, Ronald P. Caputo, Taxus Iv Investigators, David A. Cox, James B. Hermiller, Thomas S. Bowman, Patrick Bergin, Mark Turco, Donald S. Baim, Tift Mann, Gregg W. Stone
Publikováno v:
JACC: Cardiovascular Interventions. 2(12):1248-1259
Objectives The pivotal TAXUS IV (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent) trial evaluated the long-term safety and effectiveness of the paclitaxel-eluting stent (PES) compared with an otherwise ident
Autor:
Howard D. Sesso, Thomas S. Bowman, J. Michael Gaziano, Catherine Rahilly-Tierney, Luc Djoussé
Publikováno v:
The American Journal of Cardiology. 102:1663-1667
The association between change in high-density lipoprotein cholesterol (HDL-C) and risk of subsequent coronary heart disease (CHD) remains unclear. We calculated the change in HDL-C in a prospective cohort of 4501 male physicians enrolled in the Phys
Publikováno v:
Nephrology Dialysis Transplantation. 23:1246-1251
Background. High blood pressure (BP) has been associated with a decrease in kidney function. However, it remains unclear which BP measure best predicts impaired kidney function. Methods. We compared systolic blood pressure (SBP), diastolic blood pres
Publikováno v:
Neurology. 67:820-823
Objective: To evaluate which blood pressure measure is the best predictor of risk of total, ischemic, and hemorrhagic stroke. Methods: The authors used a prospective cohort study among 11,466 men followed for incident stroke during a median of 19.4 y
Publikováno v:
Journal of Human Hypertension. 20:631-634
In cross-sectional studies, elevated homocysteine levels are associated with higher blood pressure, but it remains unclear whether plasma homocysteine is a risk factor for hypertension. In a prospective nested case-control study, participants who dev
Autor:
Thomas S. Bowman, J. Michael Gaziano, Howard D. Sesso, Tobias Kurth, Meir J. Stampfer, Jing Ma, Carlos S. Kase
Publikováno v:
Stroke. 34:2930-2934
Background and Purpose— Large epidemiological studies have not established cholesterol levels as a risk factor for ischemic stroke, but recent clinical trials have demonstrated a reduction in the ischemic stroke rate for patients taking HMG-CoA red